title: Membrane-anchored aspartyl protease with Alzheimer's disease beta-secretase activity.
abstract: Mutations in the gene encoding the amyloid protein precursor (APP) cause autosomal dominant Alzheimer's disease. Cleavage of APP by unidentified proteases, referred to as beta- and gamma-secretases, generates the amyloid beta-peptide, the main component of the amyloid plaques found in Alzheimer's disease patients. The disease-causing mutations flank the protease cleavage sites in APP and facilitate its cleavage. Here we identify a new membrane-bound aspartyl protease (Asp2) with beta-secretase activity. The Asp2 gene is expressed widely in brain and other tissues. Decreasing the expression of Asp2 in cells reduces amyloid beta-peptide production and blocks the accumulation of the carboxy-terminal APP fragment that is created by beta-secretase cleavage. Solubilized Asp2 protein cleaves a synthetic APP peptide substrate at the beta-secretase site, and the rate of cleavage is increased tenfold by a mutation associated with early-onset Alzheimer's disease in Sweden. Thus, Asp2 is a new protein target for drugs that are designed to block the production of amyloid beta-peptide peptide and the consequent formation of amyloid plaque in Alzheimer's disease.
authors.affiliation: Cell & Molecular Biology, Pharmacia & Upjohn, Inc., Kalamazoo, MI 49007, USA. riqiang.yan@am.pnu.com
authors.forename: R
authors.initials: R
authors.lastname: Yan
authors.forename: M J
authors.initials: MJ
authors.lastname: Bienkowski
authors.forename: M E
authors.initials: ME
authors.lastname: Shuck
authors.forename: H
authors.initials: H
authors.lastname: Miao
authors.forename: M C
authors.initials: MC
authors.lastname: Tory
authors.forename: A M
authors.initials: AM
authors.lastname: Pauley
authors.forename: J R
authors.initials: JR
authors.lastname: Brashier
authors.forename: N C
authors.initials: NC
authors.lastname: Stratman
authors.forename: W R
authors.initials: WR
authors.lastname: Mathews
authors.forename: A E
authors.initials: AE
authors.lastname: Buhl
authors.forename: D B
authors.initials: DB
authors.lastname: Carter
authors.forename: A G
authors.initials: AG
authors.lastname: Tomasselli
authors.forename: L A
authors.initials: LA
authors.lastname: Parodi
authors.forename: R L
authors.initials: RL
authors.lastname: Heinrikson
authors.forename: M E
authors.initials: ME
authors.lastname: Gurney
mesh_terms: D000544:Alzheimer Disease / Q000188:drug therapy / Q000201:enzymology*; D000595:Amino Acid Sequence; D053829:Amyloid Precursor Protein Secretases; D016229:Amyloid beta-Peptides / Q000378:metabolism; D016564:Amyloid beta-Protein Precursor / Q000378:metabolism*; D000818:Animals; D016282:Aspartic Acid Endopeptidases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D016466:CHO Cells; D017173:Caenorhabditis elegans; D002460:Cell Line; D002462:Cell Membrane / Q000201:enzymology; D006224:Cricetinae; D010450:Endopeptidases; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D051379:Mice; D008969:Molecular Sequence Data; D009154:Mutation; D016376:Oligonucleotides, Antisense / Q000235:genetics / Q000494:pharmacology; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D014018:Tissue Distribution; D014162:Transfection; D014407:Tumor Cells, Cultured
chemical_list: D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D004791:Enzyme Inhibitors; D016376:Oligonucleotides, Antisense; D011994:Recombinant Proteins; D053829:Amyloid Precursor Protein Secretases; D010450:Endopeptidases; D016282:Aspartic Acid Endopeptidases; C509284:BACE2 protein, human; C509280:BACE1 protein, human; C509282:Bace1 protein, mouse